Valeant said to weigh sale of Egyptian drugmaker Amoun: Bloomberg

(Reuters) – Valeant Pharmaceuticals International Inc is considering the sale of Egyptian drugmaker Amoun Pharmaceutical Co to accelerate its debt-reduction plan, Bloomberg reported, citing people…

Leave a Reply

Read the original at Reuters: Deals.